関係会社貸倒引当金繰入額、減価償却費 - 医薬品事業、当期変動額合計他1件
- 【期間】
| 年度 | 関係会社貸倒引当金繰入額 | 減価償却費 - 医薬品事業 | 当期変動額合計 | 長期借入金 |
|---|
| 2008/03 | - | | - | | - | | 11.7億 | |
| 2009/03 | - | | - | | 750百万 | | 15.3億 | +31.2% |
| 2010/03 | - | | - | | - | | 18.5億 | +20.9% |
| 2011/03 | 62百万 | | - | | - | | 36.2億 | +95.5% |
| 2012/03 | - | | - | | - | | 32.1億 | -11.4% |
| 2013/03 | - | | 15.9億 | | - | | 21.6億 | -32.6% |
| 2014/03 | - | | - | | - | | 13.1億 | -39.5% |
| 2015/03 | - | | - | | - | | 40.2億 | +206.8% |
| 2016/03 | - | | - | | - | | 44億 | +9.6% |
| 2017/03 | - | | - | | - | | 41億 | -6.8% |
| 2018/03 | - | | - | | - | | 28.3億 | -31.1% |
| 2019/03 | - | | - | | - | | 15.5億 | -45.1% |
| 2020/03 | - | | - | | - | | 2.79億 | -82% |
| 2021/03 | - | | - | | - | | 11.9億 | +324.3% |
| 2022/03 | - | | - | | - | | 11.9億 | ±0% |
| 2023/03 | - | | - | | - | | 64.3億 | +442.7% |
